TFRC and glioblastoma: For instance, transferrin receptor 1 (TfR1) is a promising therapeutic target due to its elevated expression in GBM.[106] Novel agents like Gallium nitrate and newer iron chelators, including VLX600 and Dp44mT, have shown efficacy.